United States Federal Circuit

ResetAA Font size: Print

Orexo AB v. Actavis Elizabeth LLC, 17-1333

Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that obviousness was not proved by clear and convincing evidence.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2018/09/10


  • Newman


  • United States Federal Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More